Yokohama, Japan

Ken-ichiro Seino

This inventor holds 1 USPTO granted patent. Top assignee: Riken Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ken-ichiro Seino. Retrieved from https://idiyas.com/inventor/ken-ichiro-seino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ken-ichiro Seino: Innovator in Immunoregulatory Compounds

Introduction

Ken-ichiro Seino is a prominent inventor based in Yokohama, Japan. He is known for his significant contributions to the field of immunology through his innovative research and patents. His work focuses on compounds that have the potential to treat autoimmune diseases.

Latest Patents

Ken-ichiro Seino holds a patent for a compound having a cyclic structure, which is represented by a specific formula. This compound includes an aldopyranose residue, a C2-18 hydrocarbon group, an acyl group, and can contain various substituents. The compound exhibits a unique immunoregulatory ability, making it useful for the prophylaxis or treatment of autoimmune diseases and similar conditions. He has 1 patent to his name.

Career Highlights

Ken-ichiro Seino is associated with Riken Corporation, a leading research institution in Japan. His work at Riken has allowed him to explore and develop innovative solutions in the field of immunology. His research has garnered attention for its potential applications in medical treatments.

Collaborations

Throughout his career, Ken-ichiro Seino has collaborated with notable colleagues, including Ken-ichi Fuhshuku and Kenji Mori. These collaborations have contributed to the advancement of research in immunoregulatory compounds.

Conclusion

Ken-ichiro Seino's contributions to the field of immunology through his innovative patents highlight his role as a key inventor. His work continues to pave the way for advancements in the treatment of autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…